Novartis buoyed by trial success in early-stage breast cancer
Novartis's (NOVN.S) Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal trial, providing a confidence boost for the drugmaker's growth prospects. The Swiss firm's shares jumped 5.8% on Monday to a four-week high by 0734…#novartis #pfizer #elilillyllyn #ericleberrigaud #vasnarasimhan #sandoz #astrazeneca #ludwigburger #friederikeheine #clarencefernandez (Source: Reuters: Health)
Source: Reuters: Health - March 27, 2023 Category: Consumer Health News Source Type: news
Women in their 20s given AstraZeneca's Covid jab are 3.5 TIMES more likely to die of cardiac arrest
Some Covid jabs given to young women early in the Covid pandemic increased their chance of a heart related death by up 3.5 times an analysis from the Office for National Statistics has found. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2023 Category: Consumer Health News Source Type: news
Love and sacrifice: The Zena Sfeir Story
It ’s funny how no one thinks they have a story worth listening to. That’s what Zena Sfeir, Aitia (formerly GNS) VP Marketing, said as we embarked on her interview. My eyes widened as her story slowly unfolded. Talk about resilience. When you combine that resilience with a huge capacity for love and a mindset of service, the sky is the limit. Zena ’s journey is proof. Zena was born and raised in Beirut towards the end of the Lebanese Civil War. So, in a way, the war felt ‘normal’ to her. Looking back decades later, she says she still remembers it as a happy childhood, despite the conflict. While her family hid ...
Source: EyeForPharma - March 16, 2023 Category: Pharmaceuticals Authors: Jill Donahue Source Type: news
AstraZeneca launches call for entries to the 2023 global R & D Postdoctoral Challenge
AstraZeneca has announced the launch of the 2023 R&D Postdoctoral Challenge, an initiative designed to accelerate ideas to transform the treatment of some of the world’s most complex diseases.
The R&D Postdoctoral Challenge has been designed to drive R&D productivity, promote diversity of thought and stimulate research opportunities across the globe. (Source: World Pharma News)
Source: World Pharma News - March 15, 2023 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
Paul Berg obituary
Nobel prizewinning biochemist who was a pioneer in the field of genetic engineeringThe Oxford-AstraZeneca vaccine against Covid-19 was built on the principle of stitching together DNA from two viruses, one to enable the vaccine to enter cells and the other to provoke an immune response.In 1972 Paul Berg, who has died aged 96, became the first person to combine the DNA of two organisms in this way. Recombinant DNA has become a fundamental tool of biomedical research and drug discovery, making it possible to grow drugs such as human insulin in bacteria as well as to develop tailor-made vaccines.Continue reading... (Source: G...
Source: Guardian Unlimited Science - March 14, 2023 Category: Science Authors: Georgina Ferry Tags: Genetics Biochemistry and molecular biology Nobel prizes US news New York Science People in science Source Type: news
AstraZeneca sells West Chester manufacturing building for $212 million
AstraZeneca sold its West Chester site 8814 Trade Port Drive for $212 million. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 10, 2023 Category: American Health Authors: Abby Miller Source Type: news
AstraZeneca sells West Chester manufacturing building for $212 million
AstraZeneca sold its West Chester site 8814 Trade Port Drive for $212 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 8, 2023 Category: Pharmaceuticals Authors: Abby Miller Source Type: news
The 4 Ps of Cancer Care: Policy, Politics, Priorities, and Prevention The 4 Ps of Cancer Care: Policy, Politics, Priorities, and Prevention
AstraZeneca ' s David Fredrickson is encouraged by the latest cancer research and discusses the four Ps: Policy, Politics, Priorities, and Prevention.WebMD (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 8, 2023 Category: Allergy & Immunology Tags: Hematology-Oncology Expert Interview Source Type: news
FDA Panel Recommends 2 RSV Vaccines for Older Adults
Signs encouraged masking in Grand Central Terminal in Manhattan this winter as R.S.V. cases surged. The virus is associated with 6,000 to 10,000 deaths each year in adults 65 and older. The shots, if approved by the agency, would be the first vaccines publicly available against a respiratory virus…#grandcentralterminal #manhattan #rsv #gsk #fda #icu #astrazeneca #pfizer #fdanorsv #millerfisher (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news
If UK wages are going down, why aren ’t rent, food and energy prices coming down too?
Recent news about the UK economy has been a series of staggering highs and lows. The highs have often featured UK companies. Profits have reached record levels, as in turn have the indices that track the value of those companies’ shares, providing a bonanza for executives and shareholders alike.…#resolutionfoundation #keynesian #ftse #bp #astrazeneca #baesystems #unilever #hsbc #anningtonhomes #angloamerican (Source: Reuters: Health)
Source: Reuters: Health - February 27, 2023 Category: Consumer Health News Source Type: news
Qure.ai secures EU medical device regulation certification
Artificial intelligence (AI) software developer Qure.ai has secured CE Clas...Read more on AuntMinnie.comRelated Reading:
Qure.ai nets $40M in new funding round
Qure.ai gets nod for AI tube placement software
Qure.ai secures FDA clearance for qER-Quant
AstraZeneca, Qure.ai partner for lung cancer diagnosis
Qure.ai adds Bresenham to advisory team (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 23, 2023 Category: Radiology Source Type: news
AstraZeneca enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate
AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targeting Claudin 18.2, a promising therapeutic target in gastric cancer. Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture and commercialisation of CMG901 globally. (Source: World Pharma News)
Source: World Pharma News - February 23, 2023 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Pfizer is ready to ram home its advantage in the respiratory syncytial virus (RSV) maternal vaccine race. | Pfizer is ready to ram home its advantage in the respiratory syncytial virus maternal vaccine race. With onetime close rival GSK still stalled, the Big Pharma has put itself on course to…#rsv #bigpharma #astrazeneca #sanofi (Source: Reuters: Health)
Source: Reuters: Health - February 22, 2023 Category: Consumer Health News Source Type: news
AstraZeneca sends updated Covid drug Evusheld to regulators for approval
An estimated 500,000 Britons are believed to still be at serious risk from infection with Covid because of conditions that weaken their immune system and make the vaccines ineffective. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2023 Category: Consumer Health News Source Type: news
AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer
Drug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary tract cancer (BTC) in the country. The company has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Durvalumab, the drug firm said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2023 Category: Pharmaceuticals Source Type: news
